Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
Vir Biotechnology (VIR)
- 8.450
- -0.200-2.31%
Close Jun 8 15:59 ET
- 8.450
- 0.0000.00%
Post 16:10 ET
1.43BMarket Cap-2.70P/E (TTM)
8.920High8.390Low1.33MVolume8.740Open8.650Prev Close11.32MTurnover1.03%Turnover RatioLossP/E (Static)168.65MShares11.66052wk High1.75P/B1.09BFloat Cap4.15552wk Low--Dividend TTM128.78MShs Float141.010Historical High--Div Yield TTM6.13%Range %4.155Historical Low8.501Avg Price1Lot Size
Vir Biotechnology (VIR) Key Financial Indicators
VIR Earnings per Share (EPS)
According to the latest financial report of Vir Biotechnology, the latest earnings per share (TTM) for the company is -0.85. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
VIR Free Cash Flow (FCF)
Interested in knowing about Vir Biotechnology's free cash flow? The latest report shows it as -132.78M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
VIR Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vir Biotechnology shows that the company's current ratio is 7.11, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
VIR Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vir Biotechnology, the quick ratio is 6.48, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
VIR Return on Equity (ROE)
Want to learn more about the financial health of Vir Biotechnology? The latest ROE figure is -15.93%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
VIR Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vir Biotechnology, the total asset return on investment (ROA) is -12.39%.
Currency: USD
Quarterly
Loading...
VIR Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vir Biotechnology's latest financial report to see how their gross margin is doing - currently at 99.96%.
Currency: USD
Quarterly
Loading...
VIR Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vir Biotechnology, the net profit margin is 433.43K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Iran's Fars News Agency, the Iranian armed forces announced the conclusion of their military operations against Israel but warn
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm